1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
2. Wang X, Teng Z, Wang H, Wang C, Liu Y, Tang Y, et al. Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a Mesoporous silica nanoparticle drug delivery system. Int J Clin Exp Pathol. 2014;7(4):1337–47.
3. Ma J, Jemal A. Breast cancer statistics. In: Ahmad A, editor. Breast cancer metastasis and drug resistance. New York: Springer; 2013.
4. Ferlay J, Héry C, Autier P, Sankaranarayanan R. Global burden of breast Cancer. In: Li C, editor. Breast cancer epidemiology. New York: Springer; 2010.
5. Trivedi PP, Kushwaha S, Tripathi DN, Jena GB. Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat. Cardiovasc Toxicol. 2011;11(3):215–25.